YoungLS. Treatment and prevention of Pneumocystis carinii pneumonia: Pathogenesis, diagnosis, treatment. New York: Marcel Dekker Inc, 1984;175–194.
7.
WhartonJM, ColemanDL, WofsyCB, . Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A prospective randomized trial. Ann Intern Med1986;105:37–44.
8.
KovacsJA, HiemenzJW, MacherAM, . Pneumocystis carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med1984;100:663–671.
9.
GordinFM, SimonGL, WofsyCB, MillsJ.Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med1984;100:495–499.
10.
NavinTR, FontaneRE. Intravenous versus intramuscular administration of pentamidine (letter). N Engl J Med1984;311:1701.
11.
WalzerPD, PerlDP, KrogstadDJ, RawsonPG, SchultzMG. Pneumocystis carinii pneumonia in the United States: Epidemiologic, diagnostic, and clinical features. Ann Intern Med1974;80:83–93.
12.
PearsonRD, HewlettEL. Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoan diseases. Ann Intern Med1985;103:782–786.
13.
LeoungGS, MillsJ, HopewellPC, HughesW, WofsyC.Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med1986;105:45–48.
14.
MedinaI, LeoungG, MillsJ, HopewellP, FeigalD, WofsyC.A randomized double blind trial of trimethoprim-sulfamethoxazole versus dapsone trimethoprim for first episode Pneumocystis carinii pneumonia in AIDS. Abstracts of Twenty Seventh Interscience Conference on Antimi-crobial Agents and Chemotherapy, New York. 1987;261.
15.
QueenerSF, BartlettMS, JayMA, DurkinMM, SmithJW. Activity of lipid soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother1987;31:1323–1327.
16.
AllegraCJ, ChabnerBA, TuazonCA, . Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med1987;317:978–985.
17.
DebsRJ, StraubingerRM, BrunetteEN, . Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes. Am Rev Respir Dis1987;135:731–737.
18.
DebsRJ, BlumenfeldW, BrunetteEN, . Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother1987;31:37–41.
19.
GirardPM, Brun-PascaudM, FarinottiR, TamisierL, KernbaumS.Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia. Antimicrob Agents Chemother1987;31:978–981.
20.
BernardEM, DonnellyHJ, HuangA, TsangS, ArmstrongD.Successful prevention and treatment of experimental Pneumocystis carinii pneumonia with aerosol pentamidine. Abstracts of II International Conference on AIDS, Paris. 1986;54.
21.
DonnellyH, BernardEM, RothkotterH, GoldJWM, ArmstrongD.Distribution of pentamidine in patients with AIDS. J Infect Dis1988;157:985–989.
22.
NewmanSP. Aerosol deposition considerations in inhalation therapy. Chest1985;88(Suppl):152S–160S.
23.
BrainJD, ValbergPA. State of the art. Deposition of aerosol in the respiratory tract. Am Rev Respir Dis1979;120:1325–1373.
24.
IlowiteJS, GorvoyJD, SmaldoneGC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis1987;136:1445–1449.
25.
NewhouseMT. Principles of aerosol therapy. Chest1982;82(Suppl):39S–41S.
26.
StuartBO, WashR.Deposition of inhaled aerosols. Arch Intern Med1973;131:60–73.
27.
NewhouseM, SanchisJ, BienenstockJ.Lung defense mechanisms. N Engl J Med1976;295:990–995, 1045–1052.
28.
NewmanSP, PellowPGD, ClarkeSW. In vitro comparison of DeVilbiss jet and ultrasonic nebulizers. Chest1987;92:991–994.
29.
SirrSA, JuenemannPJ, TomH, BoudreauRJ, ChandlerRP, LokenMK. Effects of ethanol on droplet size, efficiency of delivery, and clearance characteristics of technetium-99m DTPA aerosol. J Nucl Med1985;26:643–646.
30.
FineJM, GordonT, SheppardD.The roles of pH and ionic species in sulfur dioxide and sulfite-induced bronchoconstriction. Am Rev Respir Dis1987;136:1122–1126.
31.
MontgomeryAB, DebsRJ, LuceJM, . Selective delivery of pentamidine to the lung by aerosol. Am Rev Respir Dis1988;137:477–478.
32.
ConteJE, HollanderH, GoldenJA. Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. Ann Intern Med1987;107:495–498.
33.
MontgomeryAB, DebsRJ, LuceJM, . Aerosolized pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet1987;2:480–483.
KarboskiJA, GodleyPJ. Inhaled pentamidine and hypoglycemia (letter). Ann Intern Med1988;108:490.
36.
RainerCA, FeigalDW, LeoungG, ClementM, WofsyC.Prognosis and natural history of Pneumocystis carinii pneumonia: Indicators for early and late survival. Abstracts of III International Conference on AIDS, Washington DC. 1987;189.
37.
FischlMA, DickinsonGM, LaVoieL.Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA1988;259:1185–1189.
38.
HardyD, WolfePR, GottliebMS, KnightS, MitsuyasuR, YoungLS. Long-term follow-up of Fansidar prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS. Abstracts of the III International Conference on the Acquired Immunodeficiency Syndrome, Washington DC. 1987;202.
39.
MetrokaCE, LangeM, BraunN, O'SullivanM, JosefbergH, JacobusD.Successful chemoprophylaxis for Pneumo-cystis carinii pneumonia with dapsone in patients with AIDS and ARC. Abstracts of the III International Conference on the Acquired Immunodeficiency Syndrome, Washington DC. 1987;202.
40.
BuschDF, FollansbeeSE. Continuation therapy with pentamidine isethionate for prevention of relapse of Pneumocystis carinii pneumonia in AIDS. Abstracts of II International Conference of AIDS, Paris. 1986;38.
41.
JohnsonES, SuliemanS, PerezG, . Secondary prophylaxis of PCP in AIDS patients using bimonthly parenteral pentamidine. Abstracts of Twenty Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, New York. 1987;262.
42.
HughesWT, KuhnS, ChaudharyS, . Successful chemoprophylaxis for Pneumocystis carinii pneumonia. N Engl J Med1987;297:1419–1426.
43.
HughesWT, RiveraGK, SchellMJ, ThorntonD, LottL.Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonia. N Engl J Med1987;316:1627–1632.
44.
KaplanLD, WongR, WofsyC, VolberdingPA. Trimethoprim-sulfamethoxazole prophylaxis of Pneumocystis carinii pneumonia in AIDS. Abstracts of II International Conference on AIDS, Paris. 1986;53.
45.
RichmanDD, MischMA, GriecoMH, . The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double blind, placebo-controlled trial. N Engl J Med1987;317:192–197.
46.
KobrinskyNL, RansyNKC. Acute megaloblastic anemia induced by high-dose trimethoprim-sulfamethoxazole. Ann Intern Med1987;94:780–781.
47.
FischlMA, DickinsonGM. Fansidar prophylaxis of pneumocystic pneumonia in the acquired immunodeficiency syndrome (letter). Ann Intern Med1986;105:629.
48.
LeoungGS, MontgomeryAB, AbramsDA, CorkeryK, WardlawL, FeigalDW. Aerosol pentamidine for Pneumocystis carinii pneumonia: A randomized trial of 439 patients. Abstracts of IV International Conference on AIDS, Stockholm. 1988: in press.
49.
FallatRJ, KandalK, FeigalDW. Pentamidine aerosol to prevent Pneumocystis carinii pneumonia (abstract). Am Rev Respir Dis1988;137(4, Part 2):120.
50.
LoweryS, FallatR, ReigalDW, MontgomeryAB, BergeJ.Changing patterns of Pneumocystis carinii pneumonia on pentamidine aerosol prophylaxis. Abstracts of IV International Conference on AIDS, Stockholm. 1988: in press.
51.
BernardE, SchmittH, PagelL, SeltzerM, ArmstrongD.Safety and effectiveness of aerosol pentamidine for prevention of PCP in patients with AIDS. Abstracts of Twenty Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, New York. 1987;262.
52.
FeigalDW, EdisonR, LeoungGS, MontgomeryAB, ClementM, VolberdingPA. Recurrent Pneumocystis carinii pneumonia in 201 patients before AZT or prophylaxis: Implications for clinical trials. Abstracts of IV International Conference on AIDS, Stockholm. 1988: in press.